Nuovo virus influenzale di tipo A(H1N1)
Ad aprile, si sono registrati in Messico casi di infezione nell’uomo da nuovo virus influenzale di tipo A(H1N1), precedentemente identificato come influenza suina, mai rilevato prima nell’uomo. Il 24 aprile, l'Oms ha allertato i governi sui possibili rischi connessi alla diffusione di questa nuova influenza nell'uomo e al suo potenziale pandemico, alzando rapidamente il livello di attenzione per la preparazione e la risposta a una pandemia influenzale. L'11 giugno, l'Oms ha portato il livello a 6 su 6, dichiarando il periodo pandemico della nuova influenza, cioè l'aumentata e prolungata trasmissione del virus nella popolazione in numerosi Paesi del mondo, L'Oms ha sottolineato il carattere "moderato" di questa pandemic. As stated by Deputy Minister Ferruccio Fazio, the highest level of alert for the new flu "is not due to the severity of clinical symptoms, but the large geographical spread of the virus."
Crisis Unit
The Ministry has set up a crisis unit, headed by Vice Minister Ferruccio Fazio, for surveillance and prevention of influenza by a new virus A (H1N1) and the implementation of the Plan, agreed with other European Union countries, preparedness and response to pandemic influenza.
Vaccination against the new flu
The best weapon of prevention is vaccination of the population. The Deputy Minister of Health Prof. Ferruccio Fazio has signed on 11 September, the Order on "Urgent measures on Pandemic Influenza H1N1 vaccination." The measure identifies the categories of persons to which it is the offer of influenza vaccination with pandemic H1N1 vaccine from the time of the actual availability of the vaccine (the delivery to the regions and autonomous provinces is planned for the period 15 October to 15 November 2009 ) to cover at least 40% of the population residing in Italia.In order of priority will be given to offering vaccination:
people identified as being essential for the maintenance of continuity of care and occupational health staff and social health, public security forces personnel and civil defense, government personnel, agencies and companies to ensure essential public services, regular blood donors;
women in the second or third trimester of pregnancy;
people at risk, aged between 6 months and 65 years;
people aged between 6 months and 17 years, not included in the preceding paragraphs, on the basis of the technical updates of the information or authorized by the EMEA will be provided by the National Health Council;
people between 18 and 27 years, not included in the above paragraphs.
In particular, those considered at risk suffered from: chronic diseases affecting the respiratory system, including asthma, bronchopulmonary dysplasia, cystic fibrosis, COPD, cardiovascular diseases, including congenital and acquired heart disease, diabetes mellitus and other metabolic diseases, renal diseases with impaired renal diseases forming organs and hemoglobinopathies, cancer, severe liver disease and cirrhosis of the liver, congenital and acquired diseases involving inadequate production of antibodies, immunosuppression induced by drugs or HIV, chronic inflammatory diseases and intestinal malabsorption syndromes, diseases associated with an increased risk of aspiration respiratory secretions, such as neuromuscular diseases, obesity con Indice di massa corporea (BMI) > 30 e gravi patologie concomitanti; condizione di familiare o di contatto stretto di soggetti ad alto rischio che, per controindicazioni temporanee o permanenti, non possono essere vaccinati. In base alla disponibilità di vaccino pandemico nel corso della campagna vaccinale potranno essere inserite nel programma anche altre categorie di soggetti.
Con riguardo alle vaccinazioni delle donne in gravidanza, ai soggetti dai 6 mesi ai 17 anni e alle covaccinazioni, verrà emanata una successiva Ordinanza dettagliata a seguito del Parere del Consiglio Superiore di Sanità.
Sorveglianza
È stata rafforzata la rete di sorveglianza epidemiologica e virologica Influenza (the network Influnet) to allow the collection of information and virus samples for the early recognition of influenza cases and the subsequent adoption of public health measures. The main information for the operators are contained in the circular of 27 July 2009, which updates the circular of 20 May, with directions for the prevention, surveillance and control of a new influenza virus influenza A (H1N1).
Antiviral drugs for prophylaxis and treatment of cases will be enhanced the national stock of antiviral drugs already in use. The Ministry, in the circular of July 22, 2009, on 'Update of information about use of antiviral drugs for influenza virus influenza A (H1N1) v "and addressed to operarori health, provides further guidance regarding the proper use of antiviral drugs in the treatment and prophylaxis of influenza virus, new A (H1N1 ).
Latest Press Releases
influenza A/H1N1: Deputy Ferruccio Fazio SIGNS ORDER ON vaccination
Press Release of September 11, 2009 - No. 381
INFLUENZA H1N1. PRESS CONFERENCE and Deputy Minister Gelmini FAZIO
Press Release of September 8, 2009 - No. 379
H1N1 INFLUENZA: INFORMATION FROM MINISTRY ON PATIENT DIED IN NAPLES
Press Release of September 4, 2009 - No. 376
H1N1 INFLUENZA: THE MINISTRY OF PRESS CONFERENCE TODAY
Press Release of September 2, 2009 - No. 373
H1N1 INFLUENZA: MINISTRY OF COMMUNICATIONS
Press Release of August 29, 2009 - n ° 370
Crisis Unit
The Ministry has set up a crisis unit, headed by Vice Minister Ferruccio Fazio, for surveillance and prevention of influenza by a new virus A (H1N1) and the implementation of the Plan, agreed with other European Union countries, preparedness and response to pandemic influenza.
Vaccination against the new flu
The best weapon of prevention is vaccination of the population. The Deputy Minister of Health Prof. Ferruccio Fazio has signed on 11 September, the Order on "Urgent measures on Pandemic Influenza H1N1 vaccination." The measure identifies the categories of persons to which it is the offer of influenza vaccination with pandemic H1N1 vaccine from the time of the actual availability of the vaccine (the delivery to the regions and autonomous provinces is planned for the period 15 October to 15 November 2009 ) to cover at least 40% of the population residing in Italia.In order of priority will be given to offering vaccination:
people identified as being essential for the maintenance of continuity of care and occupational health staff and social health, public security forces personnel and civil defense, government personnel, agencies and companies to ensure essential public services, regular blood donors;
women in the second or third trimester of pregnancy;
people at risk, aged between 6 months and 65 years;
people aged between 6 months and 17 years, not included in the preceding paragraphs, on the basis of the technical updates of the information or authorized by the EMEA will be provided by the National Health Council;
people between 18 and 27 years, not included in the above paragraphs.
In particular, those considered at risk suffered from: chronic diseases affecting the respiratory system, including asthma, bronchopulmonary dysplasia, cystic fibrosis, COPD, cardiovascular diseases, including congenital and acquired heart disease, diabetes mellitus and other metabolic diseases, renal diseases with impaired renal diseases forming organs and hemoglobinopathies, cancer, severe liver disease and cirrhosis of the liver, congenital and acquired diseases involving inadequate production of antibodies, immunosuppression induced by drugs or HIV, chronic inflammatory diseases and intestinal malabsorption syndromes, diseases associated with an increased risk of aspiration respiratory secretions, such as neuromuscular diseases, obesity con Indice di massa corporea (BMI) > 30 e gravi patologie concomitanti; condizione di familiare o di contatto stretto di soggetti ad alto rischio che, per controindicazioni temporanee o permanenti, non possono essere vaccinati. In base alla disponibilità di vaccino pandemico nel corso della campagna vaccinale potranno essere inserite nel programma anche altre categorie di soggetti.
Con riguardo alle vaccinazioni delle donne in gravidanza, ai soggetti dai 6 mesi ai 17 anni e alle covaccinazioni, verrà emanata una successiva Ordinanza dettagliata a seguito del Parere del Consiglio Superiore di Sanità.
Sorveglianza
È stata rafforzata la rete di sorveglianza epidemiologica e virologica Influenza (the network Influnet) to allow the collection of information and virus samples for the early recognition of influenza cases and the subsequent adoption of public health measures. The main information for the operators are contained in the circular of 27 July 2009, which updates the circular of 20 May, with directions for the prevention, surveillance and control of a new influenza virus influenza A (H1N1).
Antiviral drugs for prophylaxis and treatment of cases will be enhanced the national stock of antiviral drugs already in use. The Ministry, in the circular of July 22, 2009, on 'Update of information about use of antiviral drugs for influenza virus influenza A (H1N1) v "and addressed to operarori health, provides further guidance regarding the proper use of antiviral drugs in the treatment and prophylaxis of influenza virus, new A (H1N1 ).
Latest Press Releases
influenza A/H1N1: Deputy Ferruccio Fazio SIGNS ORDER ON vaccination
Press Release of September 11, 2009 - No. 381
INFLUENZA H1N1. PRESS CONFERENCE and Deputy Minister Gelmini FAZIO
Press Release of September 8, 2009 - No. 379
H1N1 INFLUENZA: INFORMATION FROM MINISTRY ON PATIENT DIED IN NAPLES
Press Release of September 4, 2009 - No. 376
H1N1 INFLUENZA: THE MINISTRY OF PRESS CONFERENCE TODAY
Press Release of September 2, 2009 - No. 373
H1N1 INFLUENZA: MINISTRY OF COMMUNICATIONS
Press Release of August 29, 2009 - n ° 370
0 comments:
Post a Comment